Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 371,051 |
|
|||||
| News | (5) | ||||||
| Day High | 15.1875 | Low High |
|||||
| Day Low | 14.55 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Stoke Therapeutics Inc | STOK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.35 | -2.30% | 14.86 | 16:00:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.845 | 14.55 | 15.1875 | 14.86 | 15.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,264 | 371,051 | $ 14.80 | $ 5,493,360 | - | 3.35 - 16.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:53:30 | priorref | 11,500 | $ 14.86 | USD |
Stoke Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 663.11M | 44.65M | - | 8.78M | -104.7M | -2.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Stoke Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STOK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.90 | 16.69 | 13.90 | 15.31 | 850,545 | 0.96 | 6.91% |
| 1 Month | 12.14 | 16.69 | 11.01 | 14.48 | 779,747 | 2.72 | 22.41% |
| 3 Months | 6.48 | 16.69 | 5.60 | 12.33 | 1,536,492 | 8.38 | 129.32% |
| 6 Months | 4.27 | 16.69 | 4.09 | 11.35 | 839,579 | 10.59 | 248.01% |
| 1 Year | 13.15 | 16.69 | 3.35 | 10.06 | 580,770 | 1.71 | 13.00% |
| 3 Years | 37.85 | 41.60 | 3.35 | 12.83 | 363,028 | -22.99 | -60.74% |
| 5 Years | 27.21 | 71.58 | 3.35 | 17.47 | 284,129 | -12.35 | -45.39% |
Stoke Therapeutics Description
| Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. |
